HER2 positive breast cancer cases showed slightly higher expression of CNTN-1 mRNA expression (5.92-fold) while HER2 negative breast cancer cases had lower CNTN-1 mRNA expression (4.26-fold) comparatively (p=0.04). Here, ERBB2 is linked to breast carcinoma.